Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hypoxia-inducible factor-prolyl hydroxylases (HIF-PHDs) are a family of iron- and 2-oxoglutarate-dependent enzymes that play a central role in cellular oxygen sensing. They regulate the stability of hypoxia-inducible factors (HIFs), which are transcription factors critical for the cellular response to low oxygen levels (hypoxia). PHD2 is considered the principal oxygen sensor among these isoforms.
Inhibition of HIF-PHD leads to stabilization and activation of hypoxia-inducible factors (HIFs), even under normoxic conditions.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hypoxia-inducible factor-prolyl hydroxylase (PHD).